Market Trends– category –
-
KyooBe Tech Unveils Rapid Vaccine Development Method with Low-Energy Electron Beam Irradiation (LEEI): Potential for Distributed Production and CGT Applications
BioSpace USA Overview KyooBe Tech has advanced a new method for vaccine development utilizing low-energy electron beam irradiation (LEEI) for rapid pathogen inactivation. This technology can process up to 300 mL of liquid per hour, with ... -
Gyros Protein Technologies Streamlines Biotherapeutic Impurity Testing with Automated Immunoassay Platform: Enhancing Reproducibility and Throughput
Bioprocess International (via Gyros Protein Technologies webcast summary) USA Overview Gyros Protein Technologies is addressing impurity testing challenges in biotherapeutic development with its Gyrolab automated immunoassay platform. Th... -
Data Integrity Secured in Automated Bioprocesses: Middleware Ensures FDA 21 CFR Part 11 Compliance with Robust Audit Trails and Real-time Capture
Technology Networks USA Overview Ensuring data integrity in automated bioprocesses is paramount, necessitating compliance with regulatory frameworks like US 21 CFR Part 11 and ALCOA+ principles. Middleware solutions are crucial for preve... -
SNS Insider Analysis: Viral Vector Manufacturing Market Surges as Leading CDMOs Expand Capacity with Advanced AAV and Lentiviral Technologies
SNS Insider India Overview SNS Insider's market overview highlights that the increasing number of gene therapy clinical trials and the reliance on CDMOs are driving growth in the viral vector manufacturing market. Key CDMOs like Fujifilm... -
6th iPSC Drug Development Summit to Address GMP Scale-Up Challenges, Focusing on Gene Editing Safety and QC Frameworks
BioInsights International Overview The 6th iPSC Drug Development Summit will primarily focus on challenges associated with scaling iPSC platforms to GMP standards. Key discussions will cover implementing GMP-compatible gene editing strat... -
Closed-System Semi-Automated Manufacturing Key to Expanding CAR-T Access in Low- and Middle-Income Countries by Reducing Cost and Complexity
PubMed International Overview CAR-T cell therapy adoption in low- and middle-income countries (LMICs) has been severely constrained by high costs, insufficient infrastructure, and complex regulatory demands. However, the advent of closed... -
Market Report: Global Single-Use Bioreactor Market to Surge, Thermo Fisher and AGC Biologics Expand Capacity
GlobeNewswire Global Overview This article summarizes the market research report "Global Single-use Bioreactors Market Forecast to Surge from USD 3.61 Billion in 2025 to USD 15.11 Billion by 2034." The global single-use bioreactors marke... -
Academic Point-of-Care Manufacturing Offers Cost-Effective CAR-T Access in Low- and Middle-Income Countries
PubMed Global Overview CAR-T cell therapy implementation in Low- and Middle-Income Countries (LMICs) faces significant hurdles due to insufficient infrastructure, complex regulations, and high costs. However, this review suggests that ad... -
GEA Expands Biotech Scale-Up with New $4.7M Sarstedt Technology Center for Precision Fermentation & Cell Cultivation
PPTI News Germany Overview GEA has opened a new US$4.7 million biotech Application and Technology Center in Sarstedt, Germany, dedicated to expanding capabilities in precision fermentation, cell cultivation, and industrial process scale-... -
Market Report: US Autologous CAR-T Cell Therapy Process Optimization Market Driven by Efficiency & Cost Reduction Needs
Intel Market Research USA Overview This article summarizes the "United States Autologous CART Cell Therapy Process Optimization Market Outlook 2026-2034" report. The US autologous CAR-T cell therapy process optimization market is driven ...
